Background: Turnaround time (TAT) is one of the most important indicators of laboratory quality. For the outpatient routine chemistry tests whose results are checked by clinicians on the same day, we set a quality goal that >90% of these samples should be reported within 60 min. As more than 20% of the samples failed to achieve this goal in 2020, we introduced an additional autoanalyzer and a real-time monitoring system to improve this rate.

Methods: As the TAT of the pre-analytical phase is the greatest contributor to TAT, we divided it into sampling, sample transport, and sample preparation times. An additional autoanalyzer was introduced, and its effect on TAT improvement was evaluated with the TAT data of June and July 2020. A real-time monitoring system was introduced to sort delayed samples, and its effect was assessed with the TAT data of June and July 2021. TAT data from December 2019 to January 2020 were set as baseline controls.

Results: The preparation time comprised the largest proportion of TAT. Although there was a slight decrease in overall TAT after the introduction of the above two strategies, the target TAT achievement rate increased significantly from 78.5% to 88.7% (p < 0.001).

Conclusions: We checked the cause of TAT prolongation and introduced new strategies to improve it. The addition of an autoanalyzer per se was not so effective but was better when combined with the real-time monitoring system. Such strategies would increase the quality of the laboratory services.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550964PMC
http://dx.doi.org/10.1002/jcla.24665DOI Listing

Publication Analysis

Top Keywords

tat data
12
tat
10
turnaround time
8
additional autoanalyzer
8
real-time monitoring
8
monitoring system
8
data june
8
june july
8
strategies shorten
4
shorten turnaround
4

Similar Publications

Objective: This study aimed to assess the effectiveness of a dual digital alert system and automatic radiologist reassignment in improving the efficiency of quantitative imaging report delivery for clinical trials.

Materials And Methods: Assessing tumor metrics is critical to oncologic disease management, informed treatment planning, and for monitoring therapeutic response and even more so in cancer clinical research trials. A collaborative effort with the Institutional Research Information Systems division led to developing a web-based system with a Java backend, tested using Agile methodology to improve patient care with improved turnaround time (TAT) of quantitative reports.

View Article and Find Full Text PDF

TAT-1, a phosphatidylserine flippase, affects molting and regulates membrane trafficking in the epidermis of C. elegans.

Genetics

December 2024

Department of Molecular Biology, College of Agriculture, Life Sciences and Natural Resources, University of Wyoming, Laramie, Wyoming 82071.

Membrane trafficking is a conserved process required for import, export, movement, and distribution of proteins and other macromolecules within cells. The Caenorhabditis elegans NIMA-related kinases NEKL-2 (human NEK8/9) and NEKL-3 (human NEK6/7) are conserved regulators of membrane trafficking and are required for the completion of molting. Using a genetic approach we identified reduction-of-function mutations in tat-1 that suppress nekl-associated molting defects.

View Article and Find Full Text PDF

Introduction: Alzheimer's disease (AD) and other tauopathies are characterized by intracellular aggregates of microtubule-associated protein tau that are actively released and promote proteopathic spread. Microglia engulf pathological proteins, but how they endocytose tau is unknown.

Methods: We measured endocytosis of different tau species by microglia after pharmacological modulation of macropinocytosis or clathrin-mediated endocytosis (CME) or antagonism/genetic depletion of known tau receptors heparan-sulfate proteoglycans (HSPGs) and low-density lipoprotein receptor-related protein 1 (LRP1).

View Article and Find Full Text PDF

Background: Venous thromboembolic events (VTEs) are the second-leading cause of death in cancer patients, with an incidence of 5%-17% in lymphoma patients, particularly higher in those with non-Hodgkin lymphoma (NHL). Existing risk assessment models (RAMs) like the Khorana and ThroLy scores have limitations and are inadequately validated for NHL patients. Coagulation markers such as D-dimer, thrombin-antithrombin complex (TAT), and thrombomodulin (TM) show a potential predictive value for cancer-associated VTE but lack extensive research in NHL.

View Article and Find Full Text PDF

Background: Accurate fasting plasma glucose (FPG) trend prediction is important for management and treatment of patients with type 2 diabetes mellitus (T2DM), a globally prevalent chronic disease. (Generalised) linear mixed-effects (LME) models and machine learning (ML) are commonly used to analyse longitudinal data; however, the former is insufficient for dealing with complex, nonlinear data, whereas with the latter, random effects are ignored. The aim of this study was to develop LME, back propagation neural network (BPNN), and mixed-effects NN models that combine the 2 to predict FPG levels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!